Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

Official record

Identifier

NCT01915225

Recruiting locations

country

United States

Interventions studied

Not provided in the official record

Lead sponsor

National Cancer Institute (NCI)

Target enrolment

1800 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Recruiting

First posted

Aug 2, 2013

Last updated on the registry

Oct 1, 2026

Age

2 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

* INCLUSION CRITERIA:
* Participants must be 2 years of age or older. Note: Participants greater than or equal to 2 and \< 18 years of age may only participate in research sample collection if the tissue acquisition is performed during a clinically indicated surgical procedure, and the biospecimen sampling (e.g., blood, urine, ascites, bile, or \[clinically indicated\] resected tumor tissue) does not add risk to the clinically indicated procedures.
* Participants who have premalignant, primary, or metastatic solid tumors based upon either radiographic or clinical suspicion, biochemical testing, a genetic predisposition, or histological/cytological analysis that requires surgery or biopsy as part of the diagnosis, prevention, treatment, and/or follow-up.
* Participants without solid tumors in whom a diagnostic, preventative, or therapeutic intervention is being performed, but for whom surgical quality and safety outcomes data are generated.
* Participants should have laboratory and physical examination parameters within acceptable limits prior to biopsy or surgery.
* Participants must be planning to undergo surgery or biopsy as part of their normal treatment plan.
* Ability of participant, parent/guardian or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document.

EXCLUSION CRITERIA:

None.

Indexed under

Gastric Cancer